Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia

Peter J. Kerr, Isabella M. Cattadori, Matthew B. Rogers, Adam Fitch, Adam Geber, June Liu, Derek G. Sim, Brian Boag, John Sebastian Eden, Elodie Ghedin, Andrew F. Read, Edward C. Holmes

Research output: Contribution to journalArticle

Abstract

The co-evolution of myxoma virus (MYXV) and the European rabbit occurred independently in Australia and Europe from different progenitor viruses. Although this is the canonical study of the evolution of virulence, whether the genomic and phenotypic outcomes of MYXV evolution in Europe mirror those observed in Australia is unknown. We addressed this question using viruses isolated in the United Kingdom early in the MYXV epizootic (1954–1955) and between 2008–2013. The later UK viruses fell into three distinct lineages indicative of a long period of separation and independent evolution. Although rates of evolutionary change were almost identical to those previously described for MYXV in Australia and strongly clock-like, genome evolution in the UK and Australia showed little convergence. The phenotypes of eight UK viruses from three lineages were characterized in laboratory rabbits and compared to the progenitor (release) Lausanne strain. Inferred virulence ranged from highly virulent (grade 1) to highly attenuated (grade 5). Two broad disease types were seen: cutaneous nodular myxomatosis characterized by multiple raised secondary cutaneous lesions, or an amyxomatous phenotype with few or no secondary lesions. A novel clinical outcome was acute death with pulmonary oedema and haemorrhage, often associated with bacteria in many tissues but an absence of inflammatory cells. Notably, reading frame disruptions in genes defined as essential for virulence in the progenitor Lausanne strain were compatible with the acquisition of high virulence. Combined, these data support a model of ongoing host-pathogen co-evolution in which multiple genetic pathways can produce successful outcomes in the field that involve both different virulence grades and disease phenotypes, with alterations in tissue tropism and disease mechanisms.

Original languageEnglish (US)
Article numbere1006252
JournalPLoS Pathogens
Volume13
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Myxoma virus
Virulence
Viruses
Phenotype
Rabbits
Reading Frames
Skin
Tropism
Pulmonary Edema
United Kingdom
Genome
Hemorrhage
Bacteria
Genes

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Molecular Biology
  • Genetics
  • Virology

Cite this

Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia. / Kerr, Peter J.; Cattadori, Isabella M.; Rogers, Matthew B.; Fitch, Adam; Geber, Adam; Liu, June; Sim, Derek G.; Boag, Brian; Eden, John Sebastian; Ghedin, Elodie; Read, Andrew F.; Holmes, Edward C.

In: PLoS Pathogens, Vol. 13, No. 3, e1006252, 01.03.2017.

Research output: Contribution to journalArticle

Kerr, PJ, Cattadori, IM, Rogers, MB, Fitch, A, Geber, A, Liu, J, Sim, DG, Boag, B, Eden, JS, Ghedin, E, Read, AF & Holmes, EC 2017, 'Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia', PLoS Pathogens, vol. 13, no. 3, e1006252. https://doi.org/10.1371/journal.ppat.1006252
Kerr, Peter J. ; Cattadori, Isabella M. ; Rogers, Matthew B. ; Fitch, Adam ; Geber, Adam ; Liu, June ; Sim, Derek G. ; Boag, Brian ; Eden, John Sebastian ; Ghedin, Elodie ; Read, Andrew F. ; Holmes, Edward C. / Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia. In: PLoS Pathogens. 2017 ; Vol. 13, No. 3.
@article{32bdf2fe65394533a54dca3ea26978b5,
title = "Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia",
abstract = "The co-evolution of myxoma virus (MYXV) and the European rabbit occurred independently in Australia and Europe from different progenitor viruses. Although this is the canonical study of the evolution of virulence, whether the genomic and phenotypic outcomes of MYXV evolution in Europe mirror those observed in Australia is unknown. We addressed this question using viruses isolated in the United Kingdom early in the MYXV epizootic (1954–1955) and between 2008–2013. The later UK viruses fell into three distinct lineages indicative of a long period of separation and independent evolution. Although rates of evolutionary change were almost identical to those previously described for MYXV in Australia and strongly clock-like, genome evolution in the UK and Australia showed little convergence. The phenotypes of eight UK viruses from three lineages were characterized in laboratory rabbits and compared to the progenitor (release) Lausanne strain. Inferred virulence ranged from highly virulent (grade 1) to highly attenuated (grade 5). Two broad disease types were seen: cutaneous nodular myxomatosis characterized by multiple raised secondary cutaneous lesions, or an amyxomatous phenotype with few or no secondary lesions. A novel clinical outcome was acute death with pulmonary oedema and haemorrhage, often associated with bacteria in many tissues but an absence of inflammatory cells. Notably, reading frame disruptions in genes defined as essential for virulence in the progenitor Lausanne strain were compatible with the acquisition of high virulence. Combined, these data support a model of ongoing host-pathogen co-evolution in which multiple genetic pathways can produce successful outcomes in the field that involve both different virulence grades and disease phenotypes, with alterations in tissue tropism and disease mechanisms.",
author = "Kerr, {Peter J.} and Cattadori, {Isabella M.} and Rogers, {Matthew B.} and Adam Fitch and Adam Geber and June Liu and Sim, {Derek G.} and Brian Boag and Eden, {John Sebastian} and Elodie Ghedin and Read, {Andrew F.} and Holmes, {Edward C.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1371/journal.ppat.1006252",
language = "English (US)",
volume = "13",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia

AU - Kerr, Peter J.

AU - Cattadori, Isabella M.

AU - Rogers, Matthew B.

AU - Fitch, Adam

AU - Geber, Adam

AU - Liu, June

AU - Sim, Derek G.

AU - Boag, Brian

AU - Eden, John Sebastian

AU - Ghedin, Elodie

AU - Read, Andrew F.

AU - Holmes, Edward C.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The co-evolution of myxoma virus (MYXV) and the European rabbit occurred independently in Australia and Europe from different progenitor viruses. Although this is the canonical study of the evolution of virulence, whether the genomic and phenotypic outcomes of MYXV evolution in Europe mirror those observed in Australia is unknown. We addressed this question using viruses isolated in the United Kingdom early in the MYXV epizootic (1954–1955) and between 2008–2013. The later UK viruses fell into three distinct lineages indicative of a long period of separation and independent evolution. Although rates of evolutionary change were almost identical to those previously described for MYXV in Australia and strongly clock-like, genome evolution in the UK and Australia showed little convergence. The phenotypes of eight UK viruses from three lineages were characterized in laboratory rabbits and compared to the progenitor (release) Lausanne strain. Inferred virulence ranged from highly virulent (grade 1) to highly attenuated (grade 5). Two broad disease types were seen: cutaneous nodular myxomatosis characterized by multiple raised secondary cutaneous lesions, or an amyxomatous phenotype with few or no secondary lesions. A novel clinical outcome was acute death with pulmonary oedema and haemorrhage, often associated with bacteria in many tissues but an absence of inflammatory cells. Notably, reading frame disruptions in genes defined as essential for virulence in the progenitor Lausanne strain were compatible with the acquisition of high virulence. Combined, these data support a model of ongoing host-pathogen co-evolution in which multiple genetic pathways can produce successful outcomes in the field that involve both different virulence grades and disease phenotypes, with alterations in tissue tropism and disease mechanisms.

AB - The co-evolution of myxoma virus (MYXV) and the European rabbit occurred independently in Australia and Europe from different progenitor viruses. Although this is the canonical study of the evolution of virulence, whether the genomic and phenotypic outcomes of MYXV evolution in Europe mirror those observed in Australia is unknown. We addressed this question using viruses isolated in the United Kingdom early in the MYXV epizootic (1954–1955) and between 2008–2013. The later UK viruses fell into three distinct lineages indicative of a long period of separation and independent evolution. Although rates of evolutionary change were almost identical to those previously described for MYXV in Australia and strongly clock-like, genome evolution in the UK and Australia showed little convergence. The phenotypes of eight UK viruses from three lineages were characterized in laboratory rabbits and compared to the progenitor (release) Lausanne strain. Inferred virulence ranged from highly virulent (grade 1) to highly attenuated (grade 5). Two broad disease types were seen: cutaneous nodular myxomatosis characterized by multiple raised secondary cutaneous lesions, or an amyxomatous phenotype with few or no secondary lesions. A novel clinical outcome was acute death with pulmonary oedema and haemorrhage, often associated with bacteria in many tissues but an absence of inflammatory cells. Notably, reading frame disruptions in genes defined as essential for virulence in the progenitor Lausanne strain were compatible with the acquisition of high virulence. Combined, these data support a model of ongoing host-pathogen co-evolution in which multiple genetic pathways can produce successful outcomes in the field that involve both different virulence grades and disease phenotypes, with alterations in tissue tropism and disease mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=85016482386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016482386&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1006252

DO - 10.1371/journal.ppat.1006252

M3 - Article

VL - 13

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 3

M1 - e1006252

ER -